From: Structured pharmaceutical care improves the health-related quality of life of patients with asthma
Participants % | |
---|---|
Education (n = 77) | |
Primary School | 2.6 |
High School | 48.1 |
Tertiary | 49.4 |
Symptoms Occurrence (n = 77) | |
Less than or 2 days in a week | 71.4 |
More than 2 days per week but not daily | 16.9 |
Daily occurrence | 11.7 |
Night-time Awakenings (n = 77) | |
Less than two times in a month | 67.5 |
Three to four times in a month | 15.6 |
More than once in a week, but not every night | 16.9 |
Use of Reliever Medications for Control (n = 77) | |
Less than or 2 days in a week | 58.4 |
More than two days in a week but not daily | 23.4 |
Daily use | 18.2 |
Adherence to Prescribed Preventer Medications (n = 69) | |
Regular usage | 56.5 |
Irregular usage | 43.5 |
Adverse Drug Events Reported (n = 77) | |
Yes | 42.9 |
No | 57.1 |
Reported Adverse Events with Preventer Medications (n = 69) | |
Regular Preventer Medicine Usage with Adverse Events | 48.7 |
Regular Preventer Medicine Usage with No Adverse Events | 51.3 |
Irregular Preventer Medicine Usage with Adverse Events | 40.0 |
Irregular Preventer Medicine Usage with No Adverse Events | 60.0 |